Raymond James Financial’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.74M Buy
339,834
+140,997
+71% +$945K ﹤0.01% 3265
2026
Q2
$760K Sell
198,837
-166
-0.1% -$803 ﹤0.01% 4199
2026
Q1
$1.05M Sell
199,003
-341
-0.2% -$2.1K ﹤0.01% 3809
2025
Q4
$1.54M Buy
199,344
+78
+0% +$695 ﹤0.01% 3478
2025
Q3
$1.76M Buy
199,266
+197,050
+8,892% +$1.47M ﹤0.01% 3262
2025
Q2
$9.2K Buy
+2,216
New +$13.9K ﹤0.01% 5951

Other funds holding VSTM

Raymond James Financial's VSTM Position: Q3 2026 in Review

Raymond James Financial increased its Verastem (VSTM) stake by 71% in Q3 2026, buying an estimated $945K and bringing the position to 339,834 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3265.

Raymond James Financial first reported a position in VSTM in Q2 2025 and has held it in 6 quarters since. 106 funds tracked by Wall St. Rank hold VSTM as of Q3 2026.

  • Raymond James Financial held 339,834 shares of Verastem worth $2.74M as of Q3 2026.
  • Raymond James Financial bought 140,997 Verastem shares in Q3 2026, an estimated $945K.
  • Verastem made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #3265 holding.
  • Raymond James Financial first reported a position in Verastem in Q2 2025 and has held it in 6 quarters since.
  • 106 funds tracked by Wall St. Rank held Verastem as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.